2025-02-012026-01-312026-01-31falseSC515025MACHINES WITH VISION LIMITED2026-05-01falseiso4217:GBPxbrli:pureSC5150252025-01-31SC5150252026-01-31SC5150252025-02-012026-01-31SC5150252024-01-31SC5150252025-01-31SC5150252024-02-012025-01-31SC515025bus:SmallEntities2025-02-012026-01-31SC515025bus:AuditExempt-NoAccountantsReport2025-02-012026-01-31SC515025bus:FullAccounts2025-02-012026-01-31SC515025bus:PrivateLimitedCompanyLtd2025-02-012026-01-31SC515025core:WithinOneYear2026-01-31SC515025core:AfterOneYear2026-01-31SC515025core:WithinOneYear2025-01-31SC515025core:AfterOneYear2025-01-31SC515025core:ShareCapital2026-01-31SC515025core:SharePremium2026-01-31SC515025core:RevaluationReserve2026-01-31SC515025core:OtherReservesSubtotal2026-01-31SC515025core:RetainedEarningsAccumulatedLosses2026-01-31SC515025core:ShareCapital2025-01-31SC515025core:SharePremium2025-01-31SC515025core:RevaluationReserve2025-01-31SC515025core:OtherReservesSubtotal2025-01-31SC515025core:RetainedEarningsAccumulatedLosses2025-01-31SC515025core:LandBuildings2026-01-31SC515025core:PlantMachinery2026-01-31SC515025core:Vehicles2026-01-31SC515025core:FurnitureFittings2026-01-31SC515025core:OfficeEquipment2026-01-31SC515025core:NetGoodwill2026-01-31SC515025core:IntangibleAssetsOtherThanGoodwill2026-01-31SC515025core:ListedExchangeTraded2026-01-31SC515025core:UnlistedNon-exchangeTraded2026-01-31SC515025core:LandBuildings2025-01-31SC515025core:PlantMachinery2025-01-31SC515025core:Vehicles2025-01-31SC515025core:FurnitureFittings2025-01-31SC515025core:OfficeEquipment2025-01-31SC515025core:NetGoodwill2025-01-31SC515025core:IntangibleAssetsOtherThanGoodwill2025-01-31SC515025core:ListedExchangeTraded2025-01-31SC515025core:UnlistedNon-exchangeTraded2025-01-31SC515025core:LandBuildings2025-02-012026-01-31SC515025core:PlantMachinery2025-02-012026-01-31SC515025core:Vehicles2025-02-012026-01-31SC515025core:FurnitureFittings2025-02-012026-01-31SC515025core:OfficeEquipment2025-02-012026-01-31SC515025core:NetGoodwill2025-02-012026-01-31SC515025core:IntangibleAssetsOtherThanGoodwill2025-02-012026-01-31SC515025core:ListedExchangeTraded2025-02-012026-01-31SC515025core:UnlistedNon-exchangeTraded2025-02-012026-01-31SC515025core:MoreThanFiveYears2025-02-012026-01-31SC515025core:Non-currentFinancialInstruments2026-01-31SC515025core:Non-currentFinancialInstruments2025-01-31SC515025dpl:CostSales2025-02-012026-01-31SC515025dpl:DistributionCosts2025-02-012026-01-31SC515025core:LandBuildings2025-02-012026-01-31SC515025core:PlantMachinery2025-02-012026-01-31SC515025core:Vehicles2025-02-012026-01-31SC515025core:FurnitureFittings2025-02-012026-01-31SC515025core:OfficeEquipment2025-02-012026-01-31SC515025dpl:AdministrativeExpenses2025-02-012026-01-31SC515025core:NetGoodwill2025-02-012026-01-31SC515025core:IntangibleAssetsOtherThanGoodwill2025-02-012026-01-31SC515025dpl:GroupUndertakings2025-02-012026-01-31SC515025dpl:ParticipatingInterests2025-02-012026-01-31SC515025dpl:GroupUndertakingscore:ListedExchangeTraded2025-02-012026-01-31SC515025core:ListedExchangeTraded2025-02-012026-01-31SC515025dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-02-012026-01-31SC515025core:UnlistedNon-exchangeTraded2025-02-012026-01-31SC515025dpl:CostSales2024-02-012025-01-31SC515025dpl:DistributionCosts2024-02-012025-01-31SC515025core:LandBuildings2024-02-012025-01-31SC515025core:PlantMachinery2024-02-012025-01-31SC515025core:Vehicles2024-02-012025-01-31SC515025core:FurnitureFittings2024-02-012025-01-31SC515025core:OfficeEquipment2024-02-012025-01-31SC515025dpl:AdministrativeExpenses2024-02-012025-01-31SC515025core:NetGoodwill2024-02-012025-01-31SC515025core:IntangibleAssetsOtherThanGoodwill2024-02-012025-01-31SC515025dpl:GroupUndertakings2024-02-012025-01-31SC515025dpl:ParticipatingInterests2024-02-012025-01-31SC515025dpl:GroupUndertakingscore:ListedExchangeTraded2024-02-012025-01-31SC515025core:ListedExchangeTraded2024-02-012025-01-31SC515025dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-02-012025-01-31SC515025core:UnlistedNon-exchangeTraded2024-02-012025-01-31SC515025core:NetGoodwill2026-01-31SC515025core:IntangibleAssetsOtherThanGoodwill2026-01-31SC515025core:LandBuildings2026-01-31SC515025core:PlantMachinery2026-01-31SC515025core:Vehicles2026-01-31SC515025core:FurnitureFittings2026-01-31SC515025core:OfficeEquipment2026-01-31SC515025core:AfterOneYear2026-01-31SC515025core:WithinOneYear2026-01-31SC515025core:ListedExchangeTraded2026-01-31SC515025core:UnlistedNon-exchangeTraded2026-01-31SC515025core:ShareCapital2026-01-31SC515025core:SharePremium2026-01-31SC515025core:RevaluationReserve2026-01-31SC515025core:OtherReservesSubtotal2026-01-31SC515025core:RetainedEarningsAccumulatedLosses2026-01-31SC515025core:NetGoodwill2025-01-31SC515025core:IntangibleAssetsOtherThanGoodwill2025-01-31SC515025core:LandBuildings2025-01-31SC515025core:PlantMachinery2025-01-31SC515025core:Vehicles2025-01-31SC515025core:FurnitureFittings2025-01-31SC515025core:OfficeEquipment2025-01-31SC515025core:AfterOneYear2025-01-31SC515025core:WithinOneYear2025-01-31SC515025core:ListedExchangeTraded2025-01-31SC515025core:UnlistedNon-exchangeTraded2025-01-31SC515025core:ShareCapital2025-01-31SC515025core:SharePremium2025-01-31SC515025core:RevaluationReserve2025-01-31SC515025core:OtherReservesSubtotal2025-01-31SC515025core:RetainedEarningsAccumulatedLosses2025-01-31SC515025core:NetGoodwill2024-01-31SC515025core:IntangibleAssetsOtherThanGoodwill2024-01-31SC515025core:LandBuildings2024-01-31SC515025core:PlantMachinery2024-01-31SC515025core:Vehicles2024-01-31SC515025core:FurnitureFittings2024-01-31SC515025core:OfficeEquipment2024-01-31SC515025core:AfterOneYear2024-01-31SC515025core:WithinOneYear2024-01-31SC515025core:ListedExchangeTraded2024-01-31SC515025core:UnlistedNon-exchangeTraded2024-01-31SC515025core:ShareCapital2024-01-31SC515025core:SharePremium2024-01-31SC515025core:RevaluationReserve2024-01-31SC515025core:OtherReservesSubtotal2024-01-31SC515025core:RetainedEarningsAccumulatedLosses2024-01-31SC515025core:AfterOneYear2025-02-012026-01-31SC515025core:WithinOneYear2025-02-012026-01-31SC515025core:Non-currentFinancialInstrumentscore:CostValuation2025-02-012026-01-31SC515025core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-02-012026-01-31SC515025core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-02-012026-01-31SC515025core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-02-012026-01-31SC515025core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-02-012026-01-31SC515025core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-02-012026-01-31SC515025core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-02-012026-01-31SC515025core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-02-012026-01-31SC515025core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-02-012026-01-31SC515025core:Non-currentFinancialInstrumentscore:CostValuation2026-01-31SC515025core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-01-31SC515025core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-01-31SC515025core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-01-31SC515025core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-01-31SC515025core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-01-31SC515025core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-01-31SC515025core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-01-31SC515025core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-01-31SC515025core:Non-currentFinancialInstrumentscore:CostValuation2025-01-31SC515025core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-01-31SC515025core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-01-31SC515025core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-01-31SC515025core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-01-31SC515025core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-01-31SC515025core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-01-31SC515025core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-01-31SC515025core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-01-31SC515025bus:Director12025-02-012026-01-31SC515025bus:Director22025-02-012026-01-31SC515025bus:Director32025-02-012026-01-31SC515025bus:Director42025-02-012026-01-31

MACHINES WITH VISION LIMITED

Registered Number
SC515025
(Scotland)

Unaudited Financial Statements for the Year ended
31 January 2026

MACHINES WITH VISION LIMITED
Company Information
for the year from 1 February 2025 to 31 January 2026

Directors

ASHBROOK, Anthony Peter, Dr
FARRUGIA, Matthew
LENNOX, Richard David
OWEN, Jonathan

Registered Address

Codebase
3 Lady Lawson Street
Edinburgh
EH3 9DR

Registered Number

SC515025 (Scotland)
MACHINES WITH VISION LIMITED
Statement of Financial Position
31 January 2026

Notes

2026

2025

£

£

£

£

Fixed assets
Intangible assets34,8526,470
Tangible assets442,73745,257
47,58951,727
Current assets
Stocks5167,720112,284
Debtors6407,854451,993
Cash at bank and on hand232,705721,067
808,2791,285,344
Creditors amounts falling due within one year7(530,469)(166,215)
Net current assets (liabilities)277,8101,119,129
Total assets less current liabilities325,3991,170,856
Net assets325,3991,170,856
Capital and reserves
Called up share capital335335
Share premium4,436,4334,436,433
Profit and loss account(4,111,369)(3,265,912)
Shareholders' funds325,3991,170,856
The financial statements were approved and authorised for issue by the Board of Directors on 1 May 2026, and are signed on its behalf by:
ASHBROOK, Anthony Peter, Dr
Director
Registered Company No. SC515025
MACHINES WITH VISION LIMITED
Notes to the Financial Statements
for the year ended 31 January 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss. The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
The company has made a loss for the year of £845,456 (2025 - £891,488). In making their going concern assessment, the Directors have considered budgets, forecast customer wins and ongoing investor support for the business and believe that based on these factors, the company can continue trading for a period of at least 12 months from the date of signing these financial statements and therefore the financial statements have been prepared on a going concern basi
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Current taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Intangible assets
Intangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated amortisation and impairment losses. Any intangible assets carried at revalued amounts, are recorded at the fair value at the date of revaluation, as determined by reference to an active market, less any subsequent accumulated amortisation and subsequent accumulated impairment losses. Intangible assets acquired as part of a business combination are only recognised separately from goodwill when they arise from contractual or other legal rights, are separable, the expected future economic benefits are probable and the cost or value can be measured reliably.
Amortisation
Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows: Development Costs - 25 % reducing balance If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.
Research and development
Research expenditure is written off in the period in which it is incurred. Development expenditure incurred is capitalised as an intangible asset only when all of the following criteria are met: • It is technically feasible to complete the intangible asset so that it will be available for use or sale; • There is the intention to complete the intangible asset and use or sell it; • There is the ability to use or sell the intangible asset; • The use or sale of the intangible asset will generate probable future economic benefits; • There are adequate technical, financial and other resources available to complete the development and to use or sell the intangible asset; and • The expenditure attributable to the intangible asset during its development can be measured reliably. Expenditure that does not meet the above criteria is expensed as incurred.
Tangible fixed assets and depreciation
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.

Reducing balance (%)
Plant and machinery25
Office Equipment25
Impairment of non-financial assets policy
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Stocks and work in progress
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship. Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
2.Average number of employees

20262025
Average number of employees during the year1914
3.Intangible assets

Other

Total

££
Cost or valuation
At 01 February 2546,12346,123
At 31 January 2646,12346,123
Amortisation and impairment
At 01 February 2539,65339,653
Charge for year1,6181,618
At 31 January 2641,27141,271
Net book value
At 31 January 264,8524,852
At 31 January 256,4706,470
4.Tangible fixed assets

Plant & machinery

Office Equipment

Total

£££
Cost or valuation
At 01 February 25103,55716,870120,427
Additions26,922-26,922
At 31 January 26130,47916,870147,349
Depreciation and impairment
At 01 February 2563,35111,81975,170
Charge for year27,2272,21529,442
At 31 January 2690,57814,034104,612
Net book value
At 31 January 2639,9012,83642,737
At 31 January 2540,2065,05145,257
5.Stocks

2026

2025

££
Raw materials and consumables167,720112,284
Total167,720112,284
6.Debtors: amounts due within one year

2026

2025

££
Trade debtors / trade receivables42,000140,649
Other debtors329,321266,850
Prepayments and accrued income36,53344,494
Total407,854451,993
7.Creditors: amounts due within one year

2026

2025

££
Trade creditors / trade payables73,0168,789
Bank borrowings and overdrafts2,01112,243
Taxation and social security190,96430,334
Other creditors264,478114,849
Total530,469166,215